Cost-Effectiveness Analysis of the Triclip™ Transcatheter Tricuspid Valve Repair System in Patients with Tricuspid Regurgitation

被引:2
作者
Kurnaz, Mustafa [1 ]
Okcun, Selin [1 ]
Kahveci, Gokhan [2 ]
Sen, Selcuk [3 ]
Kockaya, Guvenc [1 ]
机构
[1] Econix Res Anal & Consulting Corp, Teknopk, Samsun, Turkey
[2] Basaksehir Cam & Sakura City Hosp, Dept Cardiol, Istanbul, Turkey
[3] Istanbul Univ, Istanbul Fac Med, Dept Med Pharmacol, Div Clin Pharmacol, Istanbul, Turkey
关键词
Tricuspid valve repair; tricuspid regurgitation; transcatheter interventions; cost-effectiveness; VALVULAR HEART-DISEASE; HEALTH-CARE; ASSOCIATION; MANAGEMENT; FAILURE; PREVALENCE; INSIGHTS;
D O I
10.5152/AnatolJCardiol.2021.406
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Tricuspid regurgitation is o condition that affects 1.6 million patients in the United States and is independently associated with morbidity and mortality. The TriClip (TM) procedure repairs the tricuspid valve without the need for open-heart surgery. The aim of this study is to evaluate the cost-effectiveness of TriClip (TM) treatment in patients with advanced tricuspid regurgitation from the Turkish reimbursement agency perspective. Methods: Within the scope of this study, the general literature was searched in order to reach data on tricuspid regurgitation. The utilization of health care services used in the expert panel was re-calculated with the current reimbursement costs to determine the cost of heartfailure in Turkey. In this study, Markov analysis, Tornado analysis, cost-effectiveness analysis, and partitioned survival analysis have been performed to determine whether TriClip (TM) is an effective treatment method compared to medication treatment. Results: In according to calculations, 5-year survival rate was found as 49.91%for medication treatment and 57.64% for TriClip (TM) treatment. According to the analysis performed, the cost of medication treatment was calculated as (sic)3879.72 and TriCli (TM) Transcatheter Tricuspid Valve Repair System treatment as (sic)25 661.15 for a 60-month period in patients with tricuspid regurgitation and New York Heart Association III-IV. In the calculation, it was found that TriClip (TM) treatment gave patients an average of 1.64 life years and it was found to be cost-effective compared to medication treatment. Conclusions: Considering the positive effect of TriClip (TM) treatment on patients with tricuspid regurgitation in terms of mortality and regression of the heart failure stage, as recommended in the guidelines, widespread of its use has great importance.
引用
收藏
页码:198 / 209
页数:12
相关论文
共 42 条
[1]  
Abbott, 2020, TRICLIPT EMEA VAL DO
[2]  
Abbott, ABB TRICLIPT BEC 1 D
[3]   Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function [J].
Ahmed, A ;
Aronow, WS ;
Fleg, JL .
AMERICAN HEART JOURNAL, 2006, 151 (02) :444-450
[5]   Tricuspid Regurgitation in Patients With Pacemakers and Implantable Cardiac Defibrillators: A Comprehensive Review [J].
Al-Bawardy, Rasha ;
Krishnaswamy, Amar ;
Bhargava, Mandeep ;
Dunn, Justin ;
Wazni, Oussama ;
Tuzcu, E. Murat ;
Stewart, William ;
Kapadia, Samir R. .
CLINICAL CARDIOLOGY, 2013, 36 (05) :249-254
[6]   Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study [J].
Andell, Pontus ;
Li, Xinjun ;
Martinsson, Andreas ;
Andersson, Charlotte ;
Stagmo, Martin ;
Zoller, Bengt ;
Sundquist, Kristina ;
Smith, J. Gustav .
HEART, 2017, 103 (21) :1696-+
[7]  
[Anonymous], 2014, HTA 101 INTRO HLTH T
[8]   Long-Term Outcomes of the FORMA Transcatheter Tricuspid Valve Repair System for the Treatment of Severe Tricuspid Regurgitation Insights From the First-in-Human Experience [J].
Asmarats, Lluis ;
Perlman, Gidon ;
Praz, Fabien ;
Hensey, Mark ;
Chrissoheris, Michael P. ;
Philippon, Francois ;
Ofek, Hadass ;
Ye, Jian ;
Puri, Rishi ;
Pibarot, Philippe ;
Attinger, Adrian ;
Moss, Robert ;
Bedard, Elisabeth ;
Moschovitis, Aris ;
Reineke, David ;
Lauck, Sandra ;
Blanke, Philipp ;
Leipsic, Jonathon ;
Spargias, Konstantinos ;
Windecker, Stephan ;
Webb, John G. ;
Rodes-Cabau, Josep .
JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (15) :1438-1447
[9]  
Baumgartner H, 2018, EUR HEART J, V39, P1980, DOI [10.1093/eurheartj/ehx636, 10.1093/eurheartj/ehx391]
[10]   Tricuspid Regurgitation - Medical Management and Evolving Interventional Concepts [J].
Beckhoff, Frederik ;
Alushi, Brunilda ;
Jung, Christian ;
Navarese, Eliano ;
Franz, Marcus ;
Kretzschmar, Daniel ;
Wernly, Bernhard ;
Lichtenauer, Michael ;
Lauten, Alexander .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2018, 5